Plasma YKL-40 is elevated in some patients with acute myeloid leukemia [99], multiple myeloma [96,100,101], and Hodgkin lymphoma [102], and high pre-treatment plasma YKL-40 is associated with short survival [96,99,100]. The gene discussed is CHI3L1; the disease is AL amyloidosis.